Search Results - Michael Millenson
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors by Alexander W. MacFarlane, Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion Cole, Samuel Litwin, Michael Millenson, Tahseen Al‐Saleem, Adam D. Cohen, Kerry S. Campbell
Published 2017Artigo -
2
Comparison of Referring and Final Pathology for Patients With Non-Hodgkin's Lymphoma in the National Comprehensive Cancer Network by Ann S. LaCasce, Michelle E. Kho, Jonathan W. Friedberg, Joyce C. Niland, Gregory A. Abel, Maria Alma Rodriguez, Myron S. Czuczman, Michael Millenson, Andrew D. Zelenetz, Jane C. Weeks
Published 2008Artigo -
3
Radiation for diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era: Analysis of the <scp>N</scp>ational <scp>C</scp>omprehensive <scp>C</scp>ancer <scp>N</scp>etwork lymph... by Bouthaina S. Dabaja, Ann Vanderplas, Allison Crosby‐Thompson, Gregory A. Abel, Myron S. Czuczman, Jonathan W. Friedberg, Leo I. Gordon, Mark Kaminski, Joyce C. Niland, Michael Millenson, Auayporn Nademanee, Andrew D. Zelenetz, Ann S. LaCasce, Maria Alma Rodriguez
Published 2014Artigo -
4
Lack of benefit of central nervous system prophylaxis for diffuse large B‐cell lymphoma in the rituximab era by Anita Kumar, Ann Vanderplas, Ann S. LaCasce, Maria Alma Rodriguez, Allison L. Crosby, Eva M. Lepisto, Myron S. Czuczman, Auayporn Nademanee, Joyce C. Niland, Leo I. Gordon, Michael Millenson, Andrew D. Zelenetz, Jonathan W. Friedberg, Gregory A. Abel
Published 2011Artigo -
5
Transformed non‐Hodgkin lymphoma in the rituximab era: analysis of the <scp>NCCN</scp> outcomes database by Makiko Ban‐Hoefen, Ann Vanderplas, Allison Crosby‐Thompson, Gregory A. Abel, Myron S. Czuczman, Leo I. Gordon, Mark Kaminski, Jennifer L. Kelly, Michael Millenson, Auayporn Nademanee, Maria Alma Rodriguez, Andrew D. Zelenetz, Joyce C. Niland, Ann S. LaCasce, Jonathan W. Friedberg
Published 2013Artigo -
6
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database by Ann S. LaCasce, Jonathan L. Vandergrift, Maria Alma Rodriguez, Gregory A. Abel, Allison L. Crosby, Myron S. Czuczman, Auayporn Nademanee, Douglas W. Blayney, Leo I. Gordon, Michael Millenson, Ann Vanderplas, Eva M. Lepisto, Andrew D. Zelenetz, Joyce C. Niland, Jonathan W. Friedberg
Published 2012Artigo -
7
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma by Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Li Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand
Published 2014Artigo -
8
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial by Jennifer R. Brown, Mehdi Hamadani, John Hayslip, Ann Janssens, Nina D. Wagner‐Johnston, Oliver G. Ottmann, Jon Arnason, Hervé Tilly, Michael Millenson, Fritz Offner, Nashat Gabrail, Siddhartha Ganguly, Sikander Ailawadhi, Siddha Kasar, Arnon P. Kater, Jeanette K. Doorduijn, Lei Gao, Joanne Lager, Bin Wu, Coumaran Égile, Marie José Kersten
Published 2018Artigo -
9
Cancer- and Chemotherapy-Induced Anemia by George M. Rodgers, Pamela S. Becker, Morey A. Blinder, David Cella, Asher Chanan‐Khan, Charles S. Cleeland, Peter F. Coccia, Benjamin Djulbegović, Jeffrey A. Gilreath, Eric H. Kraut, Ursula A. Matulonis, Michael Millenson, Denise K. Reinke, Joseph Rosenthal, Rowena Schwartz, Gerald A. Soff, Richard S. Stein, Gordana Vlahovic, Alva B. Weir
Published 2012Artigo -
10
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era by Zheng Zhou, Laurie H. Sehn, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Andrew D. Zelenetz, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Joyce C. Niland, Randy D. Gascoyne, Joseph M. Connors, Jonathan W. Friedberg, Jane N. Winter
Published 2013Artigo -
11
Venous Thromboembolic Disease by Michael B. Streiff, Paula Bockenstedt, Spero R. Cataland, C Chesney, Charles Eby, John Fanikos, Patrick Fogarty, Shuwei Gao, Julio García‐Aguilar, Samuel Z. Goldhaber, Hani Hassoun, Paul C. Hendrie, Bjorn Holmstrom, Kimberly Jones, Nicole M. Kuderer, Jason T. Lee, Michael Millenson, Anne T. Neff, Thomas L. Ortel, Judy L. Smith, Gary C. Yee, Anaadriana Zakarija
Published 2011Artigo -
12
Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology by Peter L. Greenberg, Maria R. Baer, John M. Bennett, Clara D. Bloomfield, Carlos M. de Castro, H. Joachim Deeg, Marcel P. Devetten, Peter D. Emanuel, Harry P. Erba, E Estey, James M. Foran, Steven D. Gore, Michael Millenson, Willlis H. Navarro, Stephen D. Nimer, Margaret O’Donnell, Hussain I. Saba, Kathy Spiers, Richard M. Stone, Martin S. Tallman
Published 2006Artigo -
13
Myelodysplastic Syndromes by P Greenberg, Eyal C. Attar, John M. Bennett, Clara D. Bloomfield, Carlos M. De Castro, H. Joachim Deeg, James M. Foran, Karin Gaensler, Guillermo Garcia‐Manero, Steven D. Gore, David Head, Rami S. Komrokji, Lori J. Maness, Michael Millenson, Stephen D. Nimer, Margaret R. O'Donnell, Mark A. Schroeder, Paul J. Shami, Richard M. Stone, James E. Thompson, Peter Westervelt
Published 2011Artigo -
14
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma by John P. Leonard, Ann S. LaCasce, Mitchell R. Smith, Ariela Noy, Lucian R. Chirieac, Scott J. Rodig, Jian Yu, Shankar Vallabhajosula, Heiko Schöder, Patricia A. English, Donna Neuberg, Peter Martin, Michael Millenson, Scott Ely, Rachel Courtney, M. Naveed Shaik, Keith D. Wilner, Sophia Randolph, Annick D. Van den Abbeele, Selina Chen‐Kiang, Jeffrey T. Yap, Geoffrey I. Shapiro
Published 2012Artigo -
15
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study by Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma C. Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Li Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman
Published 2016Artigo -
16
Venous Thromboembolic Disease by Michael B. Streiff, Paula Bockenstedt, Spero R. Cataland, C Chesney, Charles Eby, John Fanikos, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Hani Hassoun, Paul C. Hendrie, Björn Holmström, Nicole M. Kuderer, Jason T. Lee, Michael Millenson, Anne T. Neff, Thomas L. Ortel, Tanya Siddiqi, Judy L. Smith, Gary C. Yee, Anaadriana Zakarija, Nicole R. McMillian, Maoko Naganuma
Published 2013Artigo -
17
Acute Myeloid Leukemia, Version 2.2013 by Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal C. Attar, Uma Borate, Steven Coutré, Lloyd E. Damon, Jeffrey E. Lancet, Lori J. Maness, Guido Marcucci, Michael G. Martin, Michael Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. Stone, Stephen A. Strickland, Eunice S. Wang, Kristina M. Gregory, Maoko Naganuma
Published 2013Artigo -
18
Myelodysplastic Syndromes by Peter L. Greenberg, Eyal C. Attar, John M. Bennett, Clara D. Bloomfield, Uma Borate, Carlos M. De Castro, H. Joachim Deeg, Olga Frankfurt, Karin Gaensler, Guillermo Garcia‐Manero, Steven D. Gore, David Head, Rami S. Komrokji, Lori J. Maness, Michael Millenson, Margaret O’Donnell, Paul J. Shami, Brady L. Stein, Richard M. Stone, James E. Thompson, Peter Westervelt, Benton M. Wheeler, Dorothy A. Shead, Maoko Naganuma
Published 2013Artigo -
19
Acute Lymphoblastic Leukemia by Joseph Alvarnas, Patrick A. Brown, Patricia Aoun, Karen K. Ballen, Naresh Bellam, William Blum, Michael W. Boyer, Hetty E. Carraway, Peter F. Coccia, Steven Coutré, Jennifer L. Cultrera, Lloyd E. Damon, Daniel J. DeAngelo, Dan Douer, Haydar Frangoul, Olga Frankfurt, Salil Goorha, Michael Millenson, Susan O’Brien, Stephen H. Petersdorf, Arati V. Rao, Stephanie Terezakis, Geoffrey L. Uy, Meir Wetzler, Andrew D. Zelenetz, Maoko Naganuma, Kristina M. Gregory
Published 2012Artigo -
20
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015 by Michael B. Streiff, Bjorn Holmstrom, Aneel A. Ashrani, Paula Bockenstedt, C Chesney, Charles Eby, John Fanikos, Randolph B. Fenninger, Annemarie E. Fogerty, Shuwei Gao, Samuel Z. Goldhaber, Paul C. Hendrie, Nicole M. Kuderer, Alfred Lee, Jason T. Lee, Mirjana Lovrincevic, Michael Millenson, Anne T. Neff, Thomas L. Ortel, Rita Paschal, Sanford J. Shattil, Tanya Siddiqi, Kristi J. Smock, Gerald A. Soff, Tzu‐Fei Wang, Gary C. Yee, Anaadriana Zakarija, Nicole R. McMillian, Anita M. Engh
Published 2015Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Oncology
Cancer
Intensive care medicine
Lymphoma
Disease
Rituximab
Chemotherapy
Diffuse large B-cell lymphoma
Leukemia
Thrombosis
Venous thromboembolism
Anemia
Biochemistry
Bone marrow
Clinical Practice
Cyclophosphamide
Follicular lymphoma
Gastroenterology
Hodgkin lymphoma
International Prognostic Index
Mantle cell lymphoma
Myelodysplastic syndromes
Myeloid leukemia
Prednisone
Surgery
Venous thromboembolic disease
Vincristine
CHOP